Post-Marketing is the crucial phase in the lifecycle of a pharmaceutical product, occurring after regulatory approval. During this stage, the drug is made readily available to the general public, allowing healthcare providers to prescribe it for their patients. This real-world usage provides an opportunity to gather extensive data on the drug’s safety, effectiveness, and any unexpected side effects.
Post-Marketing surveillance plays a pivotal role in monitoring the drug’s performance, ensuring that it continues to meet the required standards of safety and efficacy. Additionally, the concept of Conditional Market Authorization is related, as it may apply specific conditions or restrictions on a drug’s marketing and distribution to further evaluate its benefits and risks. Overall, the Post-Marketing phase is essential for ensuring the ongoing quality and safety of pharmaceutical products available to patients.
Confounding by Indication
Contact our experts today
Composed of proven experts from the pharmaceutical industry, our team is ready to answer to your needs in any
area of product development, commercialisation and early access programs, and life cycle management